| 特征 | 单因素分析 | 多因素分析 | ||
| HR (95%CI) | p值 | HR (95%CI) | p值 | |
| NRF2 |
|
|
|
|
| 高表达 | 1.00 [Reference] |
|
|
|
| 低表达 | 0.91 (0.36, 2.29) | 0.842 |
| 0.978 |
| 治疗方式 |
|
|
|
|
| 免疫治疗联合化疗 | 1.00 [Reference] |
|
|
|
| 单纯化疗 | 3.27 (1.20, 8.93) | 0.021 |
| 0.054 |
| 性别 |
|
|
|
|
| 女性 | 1.00 [Reference] |
|
|
|
| 男性 | 0.82 (0.31, 2.17) | 0.694 |
| 0.440 |
| 肝转移 |
|
|
|
|
| 是 | 1.00 [Reference] |
|
|
|
| 否 | 0.82 (0.31, 2.16) | 0.684 |
| 0.802 |
| 腹膜转移 |
|
|
|
|
| 是 | 1.00 [Reference] |
|
|
|
| 否 | 0.69 (0.25, 1.89) | 0.474 |
| 0.477 |
| PD-L1 CPS评分 |
|
|
|
|
| <5 | 1.00 [Reference] |
|
|
|
| ≥5 | 1.35 (0.47, 3.82) | 0.578 |
| 0.269 |